After years in development and outbreaks that have claimed thousands of lives, the world has its first licensed Ebola vaccine. Merck’s Ervebo&nbs...

A host of generic drug makers recently recalled their generic Zantac from the U.S. market after the FDA raised concerns about how much of an expected carcinogen was ...

Bayer’s new corporate campaign—the largest in its history—turns science into a verb. The effort, “Why We Science,” launched recently with a series of TV ads along wi...

NASH frontrunner Intercept Pharma is well on its way to market—it’s already filed Ocaliva for FDA review and will soon follow up with a filing in Europe. But in the ...

Finding the perfect name is no easy task for a new company, particularly in the exotic world of biopharma monikers. Mylan and Pfizer's Upjohn, working to close ...

Ubiquigent Limited (Ubiquigent) and LEO Pharma A/S announced today that they have entered into an option agreement granting LEO Pharma access to two novel compounds....

The Bristol-Myers Squibb-Pfizer Alliance and Fitbit announced at the TIME 100 Health Summit in New York that they are working together to help drive timely diagnosi...

Amgen (NASDAQ:AMGN) announced that the U.S. Food and Drug Administration (FDA) approved Amgen's Supplemental Biologics License Application (sBLA) for Nplate® (romip...

As little as a daily ping on your phone can boost physical activity, researchers from the Stanford University School of Medicine and their collaborators report in a...

5 - 7 November 2019, Frankfurt, Germany.CPhI Worldwide - the world's largest pharma event taking place in Frankfurt - has released the first part of its eponymous 20...